Skip to main content

Coronavirus: Vaccination

Question for Department of Health and Social Care

UIN 28110, tabled on 6 July 2021

To ask the Secretary of State for Health and Social Care, what steps his Department has taken to ensure long-term monitoring of the immune response among people who have received different covid-19 vaccines for each dose.

Answered on

14 July 2021

The National Institute for Health Research has commissioned the National Immunisation Schedule Evaluation Consortium to undertake the Com-CoV trial. This trial is gathering data on the long-term immune response of using different COVID-19 vaccines for the first and second dose. Public Health England has also undertaken follow up on people given mixed schedules as part of routine care to monitor self-reported side effects and antibody response. The results will be published in due course.